Provider
QP38-26 MHCP Pharmacy Benefit Exclusion for Avopef™, Epioxa™ HD/Epioxa, Fesilty™, Midazolam, Photrexa®, and Wainua®
Program effective Date: May 27, 2026
Documents & Forms Results
Displaying 3641 - 3650 of 3696 results
Provider
QP37-26 Commercial Pharmacy Benefit Exclusion for Epioxa™ HD/Epioxa, Fensolvi®, Fesilty™, Midazolam, Photrexa®, Wainua®, Zemaira®, and Zoladex®
Program effective Date: May 27, 2026
Provider
QP36-26 Commercial Pharmacy Benefit Exclusion for Select Medications
Program effective Date: May 27, 2026
Provider
QP35-26 Intensive Residential Treatment Services (IRTS) Prior Authorization (PA) Requirements
Program effective Date: May 27, 2026
Provider
QP34-26 Billing Changes for Opioid Treatment Programs for Minnesota Health Care Programs
Program effective Date: May 27, 2026
Provider
Compounded Medications - Commercial
Formulary Exception, Coverage Exception
Program effective Date: Jun 01, 2026
Provider
Non-Preferred Drug with Continuation of Therapy - Medicaid
Prior Authorization
Program effective Date: Jun 01, 2026
Provider
Pulmonary Arterial Hypertension - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jun 01, 2026
Provider
Galafold (migalastat) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jun 01, 2026
Provider
Erythropoietins - Commercial
Prior Authorization
Program effective Date: Jun 01, 2026